Peter Attia· MD
But I think an important message is that uh formulation is the key. So you have beta hydroxybutyrate, you have lactate, you have MCTs cross the blood brain barrier. So it's a type of fat that actually can cross.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
But I think an important message is that uh formulation is the key. So you have beta hydroxybutyrate, you have lactate, you have MCTs cross the blood brain barrier. So it's a type of fat that actually can cross.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.